FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc
Yiyi Yu(Sun Yat-sen University), Tianshu Liu(Sun Yat-sen University)
Cited by 25
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer
|Frontiers in Oncology|2021|79
Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma
|International Journal of Oncology|2017|69
SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer
|Oncology Reports|2018|19